AHR vs MRK · P/E 79, rev $1.33B vs P/E 33, rev $16.61B
American Healthcare REIT, Inc. (AHR) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
American Healthcare REIT, Inc. (AHR) is a reit - healthcare facilities company listed on US.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
Latest reported AHR revenue for 2026-06-30 was $1.33B. Net income was $54.3M. AHR currently screens at market cap $9.63B and trailing P/E 79.0.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
AHR currently screens at market cap $9.63B and trailing P/E 79.0. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the AHR and MRK stock pages for the full models.
Not investment advice.